Page 20«..10..19202122..3040..»

Category : Nanomedicine

Healthcare Nanotechnology (Nanomedicine) Market Competition, Status and Forecast, Market Size, Key Players, Regions, Growth Rate, Type, Application by…

The Healthcare Nanotechnology (Nanomedicine) Market report provides detailed information about key market dynamics such as detailed coverage, key trends, opportunities, historical and forecast market information, demand, application details, company shares and detailed information about Healthcare Nanotechnology (Nanomedicine) market structure. This market research report shows specific facts and figures on how the Healthcare Nanotechnology (Nanomedicine) market will grow over the forecast period.

This market research study is significant for manufacturers in the Healthcare Nanotechnology (Nanomedicine) market, including Healthcare Nanotechnology (Nanomedicine) stakeholders, distributors, suppliers, and investors, and it can also help them understand applicable strategies to grow in the Healthcare Nanotechnology (Nanomedicine) market. Stakeholders, investors, industry experts, as well as business researchers can influence the information and statistics offered in the market research report.

Get a Sample Copy of the Report at

About Healthcare Nanotechnology (Nanomedicine) Market Report: Nanomedicine is a promising mode of cancer treatment. With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.

Top manufacturers/players: Abbott Laboratories, Combimatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals Inc., Johnson & Johnson, Mallinckrodt Plc, Merck & Company Inc., Nanosphere Inc., Pfizer, Inc., Celgene Corporation

Healthcare Nanotechnology (Nanomedicine) Market Segment by Regions-

The Healthcare Nanotechnology (Nanomedicine) Market report delivers a basic overview of the industry including its definition, applications and manufacturing technology. Also, the Healthcare Nanotechnology (Nanomedicine) Industry report explores the international Major Market players in detail.

Healthcare Nanotechnology (Nanomedicine) Market Segment by Type:

Healthcare Nanotechnology (Nanomedicine) Market Segment by Applications:

For More Information or Query or Customization Before Buying, Visit at

Through the statistical analysis, the Healthcare Nanotechnology (Nanomedicine) Market report depicts the global market of Healthcare Nanotechnology (Nanomedicine) Industry including capacity, production, production value, cost/profit, supply/demand and import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

Table of Contents:

1 Market Overview


3GlobalHealthcare Nanotechnology (Nanomedicine)Sales,Revenue,MarketShareandCompetitionbyManufacturer(2017-2018)

4GlobalHealthcare Nanotechnology (Nanomedicine)MarketAnalysisbyRegions

5NorthAmericaHealthcare Nanotechnology (Nanomedicine)byCountry

6EuropeHealthcare Nanotechnology (Nanomedicine)byCountry

7Asia-PacificHealthcare Nanotechnology (Nanomedicine)byCountry

8SouthAmericaHealthcare Nanotechnology (Nanomedicine)byCountry

9MiddleEastandAfricaHealthcare Nanotechnology (Nanomedicine)byCountries

10GlobalHealthcare Nanotechnology (Nanomedicine)MarketSegmentbyType

11GlobalHealthcare Nanotechnology (Nanomedicine)MarketSegmentbyApplication

12Healthcare Nanotechnology (Nanomedicine)MarketForecast(2019-2024)



15 Appendix


Purchase This Report (Price 3480 $ USD for a Single-User License)

Contact Us:

Name: Ajay More

Phone:US +1424 253 0807 /UK +44 203 239 8187


In the end, the Healthcare Nanotechnology (Nanomedicine) Market report makes some important proposals for a new project of Healthcare Nanotechnology (Nanomedicine) Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2023 Global and Chinese Healthcare Nanotechnology (Nanomedicine) Market covering all important parameters.

Our Other Reports:

Lactic Starter Culture Industry: Global Market Overview, Shares, Growth, Demand and Forecast Report 2023

Core Drill Market Report 2019 With Top Countries Data: Analysis, Price and Gross Margin, Market Size, Competition by Manufacturers

Aviation Obstacle Lighting Industry: Global Market Overview, Shares, Growth, Demand, market Size, Production, Types & Applications and Forecast Report 2024

Sickle Cell Disease Treatment Market Business Opportunities, Market, Trend, Growth, Revenue, Manufacturers and Forecast from 2019-2023

Go here to see the original:
Healthcare Nanotechnology (Nanomedicine) Market Competition, Status and Forecast, Market Size, Key Players, Regions, Growth Rate, Type, Application by...

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market Overview On Product Performance 2025 – Health News Office

Transparency Market Research (TMR) has published a new report titled, Microcatheter Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026. According to the report, the global microcatheter market was valued atUS$ 162.3 Mnin 2017 and is anticipated to reach nearlyUS$ 304.5 Mnby 2026, expanding at a CAGR of around 7.5% from 2018 to 2026. Rise in adoption of minimally invasive procedures, technological advancements, increase in target patient population are likely to fuel the global microcatheter market from 2018 to 2026. Improved hospital infrastructure in developed markets such asNorth AmericaandEurope, rise in medical tourism inAsia Pacific, and advantages of minimally invasive procedures are expected to drive the microcatheter market during the forecast period.

Get PDF Brochure for Research Insights at

Rise in Adoption of Minimally Invasive Surgeries to Propel Market

Embolization is a minimally invasive surgery that marks a significant advancement in medical technology. Embolization procedures are used in the treatment of cerebral aneurysms and peripheral vascular diseases. Adoption of minimally invasive surgeries has been increasing significantly due to various advantages including less post-operative pain, less blood loss, reduced hospital stay, and faster recovery. This is likely to propel the microcatheters market during the forecast period

Increase in target patient population and Technological Advancements

Increase in the geriatric population, which is prone to neurovascular and cardiovascular diseases, is projected to drive the microcatheter market. According to the National Institute of Neurological Disorders and Stroke, nearly 30,000 people in the U.S. suffer a brain aneurysm rupture each year.

Request a Custom Report at

According to the American Heart Association, cardiovascular diseases account for around 17.3 million deaths each year, which is expected to increase to about 23.6 million by 2030. Technological advancements such as introduction of double coaxial guiding catheter technique, which is employed to treat chronic total occlusion (CTO) is driving the market. This technique places one guide catheter inside another. The advantages of passive support provided by a large guide catheter are combined with the ability to actively engage the smaller catheter into the target vessel. These developments are likely to add value to microcatheters and drive the global microcatheter market

Product Recall and Stringent Regulatory Requirement to Restrain Market

Several microcatheters witnessed recalls in the last few years due to defects in the products. This is expected to impact the demand for these devices. Product recalls also have a negative impact in the future profitability and adoption of these procedures by patients. InOctober 2016, Medtronic recalled certain lots of pipeline embolization device, Alligator retrieval device, and X-Celerator hydrophilic guide wire. The recall also included the stylet containing UltraFlow flow directed microcatheters and marathon flow directed microcatheters. Product approvals and launch of medical devices are governed by various regulations established by the U.S. FDA and other regulatory bodies operating in each country. The U.S. FDA continues to increase testing and documentation required for the clearance of devices. Similar regulations are noted in the European Union (EU),Japan, andChina. The various levels of approval processes can delay the product release in the market, which could have a negative impact on revenue

Request a Sample of Microcatheter Market:

Market inAsia Pacificto Register Exponential Growth

In terms of revenue, the microcatheter market inAsia Pacificis expected to expand at a CAGR of 7.8% during the forecast period. Increase in product launches is expected to drive theAsia Pacificmicrocatheter market. In 2018, ASAHI received chronic total occlusion (CTO) approvals for Corsair Pro Micro catheters and its Coronary Guide Wires to the include MIRACLEbros series, CONFIANZA series, FIELDER series, and Gaia series. According to the World Health Organization, most of the financial burden in health care is the responsibility of governments of countries inAsia Pacific. For instance, inChina, more than 95% of health care coverage is under public insurance schemes, which lay emphasis on catastrophic diseases and inpatient services.

Request For Discount On This Report:

Boston Scientific Corporation,Codman Neuro, Medtronic, Biometrics and Asahi InteccUSA, Inc. to Lead the Market

The report also provides profiles of leading players operating in the global microcatheter market, which include Boston Scientific Corporation,Codman Neuro, Medtronic, Biometrics, Asahi InteccUSA, Inc., Merit Medical Systems, Inc., Stryker, Terumo Medical Corporation, Tokai Medical Products, Inc., and Penumbra, Inc.

View post:
Nanomedicine Market Overview On Product Performance 2025 - Health News Office

Recommendation and review posted by Alexandra Lee Anderson

TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY Annual Meeting and in International Journal of Nanomedicine TLC590 showed…

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 21, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and oncology, recently presented data at the American Society of Anesthesiologists (ASA) ANESTHESIOLOGY annual meeting from a Phase I/II clinical trial which showed TLC590 to yield more immediate and long-lasting pain reduction than ropivacaine. In addition, in vivo findings in which TLC590 showed no dose-related toxicity and other preclinical data were recently published in the International Journal of Nanomedicine. TLC590 is a non-opioid, BioSeizer formulation of ropivacaine with the aim to manage postsurgical pain for four to seven days with a single dose, potentially deterring the use of opioids following surgery.

At ANESTHESIOLOGY 2019, which took place October 19-23 at the Orange County Convention Center in Orlando, FL, principal investigator Todd Bertoch, MD, Chief Medical Officer at JBR Clinical Research, a CenExel Clinical Research Center of Excellence, presented findings from a Phase I/II, randomized, double-blind, comparator-controlled, dose-escalation study of TLC590 following inguinal hernia repair.

Highlights from the e-poster presentation are as follows:

I am delighted to have had the opportunity to present these fantastic results, said Dr. Todd Bertoch. As a clinical researcher specializing in pain, it is so rewarding to be able to share findings that provide hope for a real, substantive weapon in the war against opioids. Clinicians have been waiting patiently for safe, easily administered, very long acting local anesthetics with a rapid onset. These data suggest that we may have found one.

Results of studies evaluating the release profile of TLC590 in vitro and its pharmacokinetics and anesthetic effect in vivo were recently published in the International Journal of Nanomedicine.

Highlights from the publication article are as follows:

The poster presentation and full text article can be accessed under Publications in the Pressroom section of TLCs website at

About TLC590

TLC590 is a non-opioid, BioSeizer sustained release formulation of ropivacaine designed to prolong the retention time of ropivacaine around the injection site as a drug depot, simultaneously extending its therapeutic period and reducing unwanted systemic exposure. A Phase II, randomized, double-blind, comparator- and placebo-controlled clinical trial to evaluate the safety, pharmacokinetics and efficacy of TLC590 following bunionectomy is ongoing.

About TLC

TLC (NASDAQ: TLC, TWO: 4152) is a clinical-stage specialty pharmaceutical company dedicated to the research and development of novel nanomedicines that maximize the potential of its proprietary lipid-assembled drug delivery platform (LipAD). TLC believes that its deep experience with liposome science allows a combination of onset speed and benefit duration, improving active drug concentrations while decreasing unwanted systemic exposures. TLCs BioSeizer technology is designed to enable local sustained release of therapeutic agents at the site of disease or injury; its NanoX active drug loading technology is designed to alter the systemic exposure of a drug, potentially reducing dosing frequency and enhancing distribution of liposome-encapsulated active agents to the desired site. These technologies are versatile in the choice of active pharmaceutical ingredients, and scalable with respect to manufacturing. TLC has a diverse, wholly owned portfolio of therapeutics that target areas of unmet medical need in pain management, ophthalmology, and oncology.

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include, without limitation, statements regarding TLCs expectations regarding the clinical development of TLC590, the clinical benefits of TLC590 for postsurgical pain management, the timing, scope, progress and outcome of the clinical trials, and the anticipated timelines for the release of clinical data. Words such as may, believe, will, expect, plan, anticipate, estimate, intend and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance and involve a number of risks, assumptions, uncertainties and factors, including risks that the outcome of any clinical trial is inherently uncertain and TLC590 or any of our other product candidates may prove to be unsafe or ineffective, or may not achieve commercial approval. Other risks are described in the Risk Factors section of TLCs annual report on Form 20-F for the year ended December 31, 2018 filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on TLCs expectations and assumptions as of the date of this press release. Actual results may differ materially from these forward-looking statements. Except as required by law, TLC expressly disclaims any responsibility to update any forward-looking statement contained herein, whether as a result of new information, future events or otherwise.

Read the original here:
TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY Annual Meeting and in International Journal of Nanomedicine TLC590 showed...

Recommendation and review posted by Alexandra Lee Anderson

Global Nanomedicine Market To Witness Steady Growth During The Forecast Period 2019-2028 – The State News – BBState

New York City, NY: October 23, 2019 Published via (Wired Release) Global Nanomedicine Market Research Reportrepresents the proficient analysis of Nanomedicine industry providing a competitive study of leading market players, market growth, consumption(sales) volume, key drivers and limiting factors, future projections for the new-comer to plan their strategies for business. Further, the report contains the study of Nanomedicine market ups and downs of the past few years and forecasts sales investment data from 2019 to 2028.

The Nanomedicine Report outlining the vitals details which are based on manufacturing region, top players, type, applications and so on will give a transparent view of Industry. The important presence of different regional and local players of Nanomedicine market is tremendously competitive. The Nanomedicine Report is beneficial to recognize the annual revenue of key players, business strategies, key company profiles and their benefaction to the market share.

Download Free Sample Copy of Nanomedicine Market Report:

Top Manufacturers Are Covered in This Report:Abbott Laboratories, Ablynx NV, Abraxis BioScience, Inc., Celgene Corporation, Teva Pharmaceutical Industries Limited, GE Healthcare Limited, Merck & Co., Inc., Pfizer Inc., Nanosphere, Inc., Johnson & Johnson Services, Inc.

This research report contains the pictorial representation of important data in the form of graphs, figures, diagrams and tables to make simplified for the users to understand the Nanomedicine market new trends clearly.

Geographically, report on Nanomedicine is based on several regions with respect to Nanomedicine export-import ratio of the region, production and sales volume, share of Nanomedicine market and growth rate of the industry. Major regions included while preparing the report areNorth America, Latin America, Europe, Middle East, Africa, and Asia Pacific.

The leading players in Nanomedicine industry are estimated to ahead on these opportunities to invade the global market. Nanomedicine market size and revenue of key players is assessed using the Bottom-up way.

Reasons for Buying Global Nanomedicine Market Report

* Report provides in-depth study on changing Nanomedicine market dynamics.

* Report offers Pin Point study on distinct factors driving and constraining industry growth.

* Technological innovation in market to study Nanomedicine market growth rate.

* Estimated Nanomedicine market growth depending on the study of historical and the present size of the industry.

Customize Report AndInquiry For The Nanomedicine Market Report:

Report Table of Content Gives Exact Idea about Global Nanomedicine Market Report:

Chapter 1explains Nanomedicine report necessary market surveillance, product price structure, and study, market scope and size forecast from 2019 to 2028. Although, Nanomedicine market activity, factors impacting the growth of business also complete analysis of current market holders.

Chapter 2offers detailing of top manufacturers of Nanomedicine market with their share, sales, and revenue.

Chapters 3, 4, 5studies Nanomedicine report competitive study based on the type of product, their regional sales and import-export study, the annual growth ratio of the market and the coming years study from 2019 to 2028.

Chapter 6offers a detailed analysis of Nanomedicine business channels, Nanomedicine market investors, vendors, Nanomedicine suppliers, dealers, Nanomedicine market opportunities and threats.

This content has been distributed via WiredRelease press release distribution service. For press release service inquiry, please reach us at[emailprotected]

Contact Us:

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876


Email ID:[emailprotected]

Read the original post:
Global Nanomedicine Market To Witness Steady Growth During The Forecast Period 2019-2028 - The State News - BBState

Recommendation and review posted by Alexandra Lee Anderson

New CBE professor Bardhan to bring image-guided techniques to fight against disease College of Engineering News Iowa State University – Iowa State…

Rizia Bardhan

With a research specialty in nanomedicine and nanophotonics and designing materials that fight diseases using image-guided techniques Rizia Bardhan will join the faculty of the Department of Chemical and Biological Engineering in January, 2020.

Bardhan, who has been hired as a tenured associate professor, comes to Iowa State from Vanderbilt University, where she has been an assistant professor in the Department of Chemical and Biomolecular Engineering since 2012.

Her research focuses on designing nanomaterials that can be activated by external stimuli and then utilize them for biomedical imaging, and image-guided drug delivery and immunotherapies across many disease models, including cancer, neurodegenerative disease and infection. She also develops point of care diagnostics that she is currently applying for early detection of preterm birth in pregnant women. Click here for more on her current research.

Prior to joining the faculty of Vanderbilt University she was a postdoctoral fellow at The Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA.

She received a B.A. in mathematics and chemistry at Westminster College, Fulton, Missouri, in 2005 and a Ph.D. in chemistry at Rice University in 2010 under the guidance of Prof. Naomi Halas, a pioneer in nanophotonics and plasmonics.

In the 2020 spring semester at Iowa State she will teach ChE 381, chemical engineering thermodynamics.

Outside of research and teaching, Bardhan enjoys spending time outdoors with her two sons Elan (3) and Jonah (5), and husband Cary Pint, who is also a new Iowa State University faculty member, joining the Department of Mechanical Engineering in January.

See original here:
New CBE professor Bardhan to bring image-guided techniques to fight against disease College of Engineering News Iowa State University - Iowa State...

Recommendation and review posted by Alexandra Lee Anderson

Start-up of the week: charging your car can be done in minutes – Innovation Origins

Your sneak preview of the future is the slogan of Innovation Origins, and thats just what we will highlight with our Start-up of the Week column. Over the past few days, five start-ups of the day have been featured and on Saturday we will choose the weeks winner.

Innovation Origins presents a Start-up of the Day each weekday

We shall consider various issues such as sustainability, developmental phase, practical application, simplicity, originality and to what extent they are in line with theSustainable Development Goals of UNESCO. They will all pass by here and at the end of the week, the Start-Up of the Week will be announced.

Moreover, our weekly winners may be awarded another prize. Because at the end of each calendar month, our readers, together with the editors of IO, will select the Start-up of the Month!

The way we use medicines is still somewhat primitive. Maybe thats not surprising, because our options are limited when it comes to taking medication. Most organs are well protected from the outside world. Nevertheless, this also means that medicines cannot be administered very effectively. Dosages are therefore often higher than necessary because they have to travel a long way through our bodies.

Sovigo wants to change this through nanotechnology. Their capsules are about 100 nanometres in size, which is 10,000th of a millimeter (!) The main advantage is that this nanomedicine is effective solely at the point where the medication is actually needed. Preliminary results are encouraging for treating intestinal disorders.

Climate change and dwindling agricultural land are major challenges for food and feed production. The supply of animal protein is particularly problematic.

The start-up Blue Planet Ecosystems, based in San Francisco and Vienna, wants to shift pisciculture (fish farming) to computerized container systems. The ecosystem is to be simulated in such a way that nature is able to grow in self-sustaining LARA systems (Land-based Automated Recirculating Aquaculture).

Lara Systeme (c) Blue Planet Ecosystems

This German start-ups drone system has brought a new automation revolution to warehouses. The flying assistants are able to make an inventory of a warehouse on their own by making a kind of digital impression of it. At present, maintaining a warehouse is a time-consuming task. Doks. Innovation promises a time gain of no less than 90% and a cost reduction of 80%. Data collected by the drones are subsequently made available in a proprietary data analysis system. Similar concepts are focused on a single management system as a rule, whereas Doks offers a universal system.

Giving freedom back to people who have limited freedom of movement. Thats the noble goal that former snowboarder Patrick Mayer has committed himself to. Mayer ended up in a wheelchair for a long time himself and personally experienced how winter can throw a spanner in the works. Moving through snow and over ice in a wheelchair or with crutches is just not much fun.

Which is why he came up with Wheelblades, a kind of mini-snowboard that gives more stability to the front wheels. For people on crutches, there is the SafetyFoot, an extra foothold for underneath crutches. And Wheelblades are also suitable for prams, so that you are able to go on a winter hike with your little one without any hassles.

Recharging: it is perhaps the greatest sore point that is associated with electric mobility. Compared to traditional refueling, it takes ages before you can get back on the road. If its up to the Israeli start-up Chakratec, this will soon be a thing of the past. Their kinetic battery fills up about as fast as your diesel tank does. Yet the potential is even greater: the battery has unlimited charging cycles and contains no pollutants.

They are setting their sights on a heroic reputation. A start-up for the benefit of humankind. What makes this mission even more challenging, is that the market in which they have delved into is dominated by Chinese companies. How do you stand out? The solution is simple and difficult at the same time. Come up with something completely new. The result is a kinetic battery with flywheel technology.

A battery can be highly innovative; but without a good charger it is of little use. Chakratec maintains that current infrastructure has been overwhelmed by reality and is suffering from too much red tape. It would be possible to create fast charging stations anywhere, even with a weak network, with the relevant fast charging technology.

The potential of Chakratecs technology has not gone unnoticed. The start-up has already won several awards, including one for best storage technology. They can add another feather in their cap because the favorable prospects for Chakratec make it the Start-up of the Week!

There is a frantic search going on around the world for efficient and sustainable batteries and the subject is also regularly addressed by Innovation Origins. At the beginning of this month, for example, we spoke to the start-up High Performance Battery, which is also trying to bring a new type of smartphone battery onto the market. Or does the future for cars lie with hydrogen technology? We sought answers to that question here in this series.

Innovation Origins is an independent news platform, which has an unconventional revenue model. We are sponsored by companies that support our mission: spreading the story of innovation. Read more here.

On Innovation Origins you can always read articles for free. We want to keep it that way. Have you enjoyed this article so much that you want to contribute to independent journalism? Click here:

Originally posted here:
Start-up of the week: charging your car can be done in minutes - Innovation Origins

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market Demand , Economy effect, Research Discoveries with Industrial Chain By 2028 – Healthcare News

New York City, NY: October 18, 2019-InternationalNanomedicine MarketResearch Report 2019 liable for its analysis which furnishes an overall assessment of Nanomedicine market including sales and evolving business sectors. The Nanomedicine report consists business overview, product offering, Nanomedicine revenue share, strategies, and service offering of these important key players in market.

This report includes several essential sections from the worldwide Nanomedicine market. Global market trends are examined with recently obtainable data concerning the amount of both Nanomedicine businesses and their market share. The report reviews how current approaches in Nanomedicine economy, ethical troubles, and also the challenges and hurdles which could limit the market.

GetNanomedicineMarketInsights That Actually Matters: To Know More RequestSample Copy@

Top Manufacturers (2019-2028) :

Abbott Laboratories, Ablynx NV, Abraxis BioScience, Inc., Celgene Corporation, Teva Pharmaceutical Industries Limited, GE Healthcare Limited, Merck & Co., Inc., Pfizer Inc., Nanosphere, Inc., Johnson & Johnson Services, Inc.

Geographically this report is classified into various essential regions, jointly with income (Mn/Bn USD), extension speed and market share (percent) manufacture, and ingestion of worldwide Nanomedicine industry in these regions, by 2017 to 2026 (projected), including North America, Europe, Middle East and Africa, Asia-Pacific and South America as well as its share (percent) and also CAGR for its projected period 2019 to 2028.

Global Nanomedicine Market Analysis by Sections:

Global nanomedicine market segmentation by product: Therapeutics, Regenerative medicine, In-vitro diagnostics, In-vivo diagnostics, Vaccines. Global nanomedicine market segmentation by application: Clinical Oncology, Infectious diseases, Clinical Cardiology, Orthopedics, Others

Remarkable highlights of Nanomedicine Market Report:

international Nanomedicine Market Overview

This Nanomedicine study supplies point-by-point assessment for modifying competitive dynamics

Marketing-strategy Analysis, Distributors/Traders

Economy effect features diagnosis

Industrial Chain, Nanomedicine Best sourcing strategy and down-stream buyers

Market contest by Players

From the Nanomedicine market research reports, the following points are included with detailed study at every stage:

Manufacturing Analysis Initiation of this Nanomedicine is studied depending on top countries, types, and applications. Here, price analysis of varied global Nanomedicine market vital players will be additionally covered.

Revenue and Sales Evaluation Both, earnings and sales are studied for different elements of this worldwide Nanomedicine market. Still another significant facet, the price that plays an essential role in the sales creation can be appraised in this section for several regions.

Segments and Effectiveness In continuation of using earnings, this report studies furnish and ingestion to its Nanomedicine market. This report also sheds light on the difference between consumption and supply, export and import data.

Competition In this section, many global Nanomedicine industry-leading players have been studied depending on their company profile, product portfolio, capacity, cost, and earnings.

Other Analysis Apart from the above vital information, demand and supply investigation to the global Nanomedicine economy, contact information from leading manufacturers, providers and key consumers can also be awarded.

Inquire/Speak To Expert for Further Detailed Information About Nanomedicine Report :

Reasons to Purchase this Report:

It helps to know that the vital Nanomedicine product sections along with their future predictions.

It aids for making informed business decisions by utilizing a complete analysis of market segments and from having whole understanding of Nanomedicine industry.

It poses a forward-looking probability on distinct facets controlling and market development.

This poses a more thorough analysis of this shifting contest dynamics and keeps you in front of competitions.

International Nanomedicine Market Forecast (2019-2028)

This poses a ten-year Nanomedicine prediction assessment fundamentally based mostly on the way the segments are forecast.

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us

Read more from the original source:
Nanomedicine Market Demand , Economy effect, Research Discoveries with Industrial Chain By 2028 - Healthcare News

Recommendation and review posted by Alexandra Lee Anderson

Polymers are Improving Our Ability to Diagnose Cancer – Advanced Science News




Molecular imaging provide a detailed glimpse into intricate biological processes and has emerged as a crucial tool in diagnosing numerous diseases and monitoring a patients response to therapy.

The development of optical contrast agents that are highly sensitive and specific to a particular disease, such as cancer, remains a great challenge for researchers. Small molecule optical contrast agents have demonstrated good biocompatibility for cancer imaging. For instance, indocyanine green (ICG), a cyanine dye, has been approved by the US Food and Drug Administration (FDA). However, poor solubility in water, aggregation-caused quenching, and rapid clearance from the body limited their application in clinic.

To overcome this disadvantage, one approach involves using polymers to improve the water solubility and extend blood circulation time of optical contrast agents.

A recent study published in WIREs Nanomedicine and Nanobiotechnology by Professor Xiqun Jiang of Nanjing University and coworkers, analyzes recent developments and challenges in the field of polymer-modified optical contrast agents to improve the sensitivity and specificity of cancer diagnosis.

A number of hydrophilic or amphiphilic polymers linked to therapeutic agents have already been approved by the FDA for clinical use. For instance, polyethylene glycol (PEG), a polyether compound made from the condensation of ethylene glycol, is generally recognized as safe and can be linked through covalent or non-covalent conjugation of PEG polymer chains to small molecules or macrostructures, such as a drug or therapeutic protein. An successful exmaple of this is DOXIL, the first FDA-approved nano-drug for cancer chemotherapy, and is comprised of PEGylated liposomal Doxorubicin.

Therefore, modification strategies which implement polymers to improve biological capabilities of therapeutics are also, logically, a promising avenue to improve the sensitivity and specificity of optical contrast agents. Polymer modification strategies create a hydrophilic layer around the optical contrast agents, endowing them with improved water solubility, and decreases the likelihood of proteins from binding to them in vivo, leading to extended blood circulation time.

Compared to always-on optical probes, which emit signals through accumulation regardless of their interaction with the target, activatable optical probes are designed in the off state and are designed to emit specific signals only in response to biomolecular recognition.

In such cases, the unique nature of the tumor microenvironment (TME) provides this opportunity as it differs from normal tissues and exhibits abnormal physiologic conditions, including weak acidity microenvironment, hypoxia, increased level of reactive oxygen and nitrogen species, as well as overexpressed enzymes. These conditions offer the potential biomolecular recognition sites to actuate the activatable optical probes with high signal-to-background ratio for cancer diagnosis.

While this field of research provides a promising strategy for developing enhanced diagnostic tools, challenges still remain before polymer-based activatable optical probes can be extended to clinical application. For instance, most polymer-based optical probes are cleared from the body via hepatobiliary excretion due to their relatively large sizes, leading to a longer retention time of probes compared to their small molecule counterparts.

Though the long-term safety of these polymer-based optical probes requires further investigation, this approach continues to offer the promise of significantly enhancing the sensitivity and specificity of cancer diagnosis to improve patient prognosis and, most importantly, survival rates.

Kindly contributed by the authors.

Original post:
Polymers are Improving Our Ability to Diagnose Cancer - Advanced Science News

Recommendation and review posted by Alexandra Lee Anderson

University gives pupils first-hand experience of nanotechnology – Wales247

Pupils have been given a unique opportunity to find out more about nanotechnology at a special Swansea University workshop aimed at inspiring scientists of the future.

NanoBach brought Year 7 & 8 pupils from across Neath Port Talbot together with students who were able to demonstrate what nanotechnology is and how it can be applied on a wider scale in everyday life

Nanoscience is the study of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering. This event aimed to give children a better understanding and spark an interest in nanotechnology.

The event was developed by Professor Steve Conlan, head of enterprise and innovation at Swansea University Medical School, who had seen the positive impact of a similar schools event held as part of Italian conference NanoGaliato has attended over the years.

Hosted at Tata Europes Academy Building in Port Talbot, the day saw nanomedicine students and researchers from the University helping the pupils as they tried out a variety of fun experiments and activities.

Year 8 pupil Mindie James, from YsgolBro Dur, said: I have learned so much. I knew nothing about nanotechnology before today and now I know loads. I really enjoyed making UV bracelets and nanoparticles, it was awesome!

Professor Conlan said: NanoBach aims to inspire Waless next generation of nanoscientists. It explored the nanomedicine, nanoenergy and nanoenvironment, which cover many aspects of the future of science and medicine.

Nanobach is the Welsh edition of the Academia di Gagaliato Globales programme, and is inspired by Nanopicolla which is hosted annually in Calabria and we were excited to be the first country to host an Academia event outside Italy.

At the end of the event the youngsters were able to show off what they had learned to their families and members of the community including the Mayor and Mayoress of Neath Port Talbot Scott and Jemma Jones.

Councillor Jones said: This was a fine example of one of largest employers, Tata Steel, working with one of our local universities to bring schools together for such a fun, educational event. We are very grateful to the Medical School for showcasing the skills needed for the workforces of the future here in Neath Port Talbot.

Head of science at Ysgol Ystalyfera Richard Morgan added: There were so many hands-on activities for the pupils, they were very engaged. This was an excellent learning opportunity outside of the classroom which gave them a great insight into possible careers and future study options.

Professor Conlan said the event had been such a success that plans were already under way for next years NanoBach.

Excerpt from:
University gives pupils first-hand experience of nanotechnology - Wales247

Recommendation and review posted by Alexandra Lee Anderson

Global Nanomedicine Market 2019-2024 Onset of Advanced Technologies to Upsurge the Growth – Materials Post

The NanomedicineMarket report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Additionally, the report also highlights market entry strategies for various companies across the globe along with pipeline and product analysis. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the Nanomedicinemarket. It has also covered and analyzed the potential of Nanomedicinemarket and provides statistics and information on market size, shares and growth factors.

Look insights of Global Nanomedicineindustry market research report at

About NanomedicineIndustry

The overviews, SWOT analysis and strategies of each vendor in the Nanomedicinemarket provide understanding about the market forces and how those can be exploited to create future opportunities.

Key Players in this Nanomedicinemarket are:

Get sample Copy of this NanomedicineMarket Report at

Production Analysis:SWOT analysis of major key players ofNanomedicineindustry based on a Strengths, Weaknesses, companys internal & external environments. , Opportunities and Threats. . It also includesProduction, Revenue, and average product price and market shares of key players. Those data are further drilled down with Manufacturing Base Distribution, Production Area and Product Type. Major points like Competitive Situation and Trends, Concentration Rate Mergers & Acquisitions, Expansion which are vital information to grow/establish a business is also provided.

Product Segment Analysis of the NanomedicineMarket is:

Product Product Type Segmentation SegmentationQuantum dotsNanoparticlesNanoshellsNanotubesNanodevices

Industry SegmentationSegmentation encompasses oncologyInfectious diseasesCardiologyOrthopedics

Look into Table of Content of NanomedicineMarket Report at

Regions Covered in NanomedicineMarket are:-

Inquire for further detailed information of NanomedicineMarket Report at:

NanomedicineMarket Report Highlights: The report provides a detailed analysis on current and future market trends to identify the investment opportunities Market forecasts till 2024, using estimated market values as the base numbers Key market trends across the business segments, Regions and Countries Key developments and strategies observed in the market NanomedicineMarket Dynamics such as Drivers, Restraints, Opportunities and other trends In-depth company profiles of key players and upcoming prominent players Growth prospects among the emerging nations through 2024 Market opportunities and recommendations for new investments

The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Nanomedicinemarket. The industry changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.

In this study, the years considered to estimate the market size of NanomedicineMarket are as follows:-

Single User Licence Price: USD 2350

No Of Pages in NanomedicineMarket Report: NOP

Purchase of NanomedicineMarket Report at:

Read more:
Global Nanomedicine Market 2019-2024 Onset of Advanced Technologies to Upsurge the Growth - Materials Post

Recommendation and review posted by Alexandra Lee Anderson

Page 20«..10..19202122..3040..»